Get the app!
Back to Trades

Lutzker Stuart

President of R&DDirectorCIK 0002009257

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
1
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Across 1 filing between 2026, Lutzker Stuart, President of R&D, Director, has disclosed $3.4M in transactions — all concentrated in ArriVent BioPharma, Inc. (AVBP). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

1 loaded
Feb 4AVBP
ArriVent BioPharma, Inc.
Lutzker StuartPresident of R&D, DirectorAward$3.4M

1 filing